A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)
Clinical trial NCT07266090 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07266090
- Sponsor
- Viatris Pharmaceuticals Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-14
- Primary completion
- 2027-10-08
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.